Adjunctive lisdexamfetamine dimesylate treatment of predominant negative symptoms of schizophrenia in clinically stable adults maintained on atypical antipsychotic agents: A 14-week trial

Authors
Category Primary study
JournalSchizophrenia Research
Year 2012
This article has no abstract
Epistemonikos ID: 8d2ec606ea815e93ede6a8311aba1057becaaeb2
First added on: Feb 06, 2025